Adverse event identification and management in locally advanced/metastatic urothelial carcinoma
touchPANEL DISCUSSION for touchONCOLOGY
Listen to an oncologist, urologist and nurse discuss adverse event identification and management with immunotherapies and targeted therapies for locally advanced or metastatic urothelial carcinoma.
The experts:
Dr Axel Merseburger, University Hospital Schleswig-Holstein, Campus Lübeck, Germany
Dr André Fay, PUCRS School of Medicine, Porto Alegre, Brazil
Ms Maria Lapuente, St Bartholomew’s Hospital, London, UK
This touchPODCAST is for HCPs outside the US only.
This activity is funded by an independent medical education grant from Astellas Inc. and Seagen…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.